Title: Biological pleurodesis with powder collagen at malignant pleural effusion
1Biological pleurodesis with powder collagen at
malignant pleural effusion
- A.Akopov, V.Egorov, V.Varlamov
- Research Institute of Pulmonology,
Saint-Petersburg, Russian Federation
2Objective
- Malignant pleural effusions are a common medical
problem. - Rapid recurrence of pleural effusions requires
repeated thoracocentesis, therefore increasing
the risk of complications. - For these reasons the increasing distribution
therapy by introduction in a pleural cavity of
various sclerosing agents (talc, tetraciclin,
bleomicin etc.) with the purpose of obliteration
of a pleural cavity and exudation discontinuance.
3Objective
- Research Institute of Pulmonology has wide
experience in application of the biological agent
- powder collagen - for achievement of pleural
obliteration in patients with spontaneous
pneumothorax. - Collagen is a natural biopolymer functioning as a
temporarily directing skeleton for regeneration
which is gradually replaced with organism's own
fabrics. - Tests of collagenic pleurodesis induction
performed on dogs resulted in the full and
uniform obliteration of dogs' pleural cavities.
Results of histological examination showed that
collagen sprayed in a pleural cavity caused sharp
fibrinotic pleurisy without stimulating
exudation.
Varlamov V.V. et al, ERJ, 1990
4Objective
- Experiments on 47 mongrel dogs
- (irritative effects on the pleura)
Preparations Changes in pleural cavity
Talc Solid adhesions
Tetracyclin No adhesions
Fibrine glue No adhesions
Calcium chloride No adhesions
Acethylcholine No adhesions
Papain Hyperemia of pleura, death of animals
Pyrogenal No adhesions
Polimerized hemoglobin No adhesions
Procollagen No adhesions
Modified collagen Solid adhesions along with whole extension
5Objective
- Comparison of recurrences in 297 patients with
primary spontaneous pneumothorax
Methods of therapy Number of patients Frequency of pneumothorax recurrences
Drainage 82 28,0
Thoracotomy, pleurectomy 112 0,9
Thoracoscopic biological pleurodesis with powder collagen 103 1,0
6Patients
- 45 patients with malignant pleural effusions and
expected survival of gt 1 month (January 1997 to
December 2002) - 19 men and 26 women at the average age of 64,3
years - Malignant pleural effusions were proved by
cytological examination (20 patients) or pleural
biopsy (25 patients) - Primary tumors were
- lung cancer - 22 patients (0,49)
- breast cancer - 17 patients (0,38)
- ovarian cancer - 4 patients (0,09)
- prostate cancer - 2 patients (0,04)
7Patients
- Side of effusions
- right-side effusions - in 22 patients (0,49)
- left-side effusions - in 20 patients (0,44)
- bilateral effusions in 3 patients (0,07)
- Complaints
- dyspnea 45 patients
- tachycardia - 39 patients
- pain - 35 patients
- All patients previously received systemic
chemotherapy which did not affect the effusions
8Method
- Powder collagen was derived from the cattle skin.
The size of particles did not exceed 0,1 mm. The
powder collagen was sterilized by placing it into
1 nitrofurilacrolein solution for 12-hours with
consequent gamma-wave irradiation for 3-hours. - The collagen was verified sterile using the
biological indicators.
9Method
- In all patients videothoracoscopy were carried
out under general endotracheal narcosis and
one-lung ventilation. - After visualisation of a pleural cavity, complete
evacuation of all remaining fluid and estimation
of the potential for lung reexpansion, 1 g of
powder collagen was insufflated under pressure of
0,2 atm. - At the end of the operation two drainage tubes
were installed. - The tubes were kept under suction (25 cm H2O) and
drainage was resumed until the fluid effused was
less than 100 mL per day. -
10Method
- Responses were classified as
- complete response (CR) at absence of clinical and
radiological recurrence - partial response (PR) at the absence of clinical
while at the presence of radiological fluid
reaccumulation which did not require additional
intervention - failure (F) reaccumulation of fluid causing
symptoms or requiring thoracocentesis. - All patients were called in for an examination
every 3-months. They all had a thorough
clinicoroentgenological examination in order to
administer (if necessary) any additional
thoracocenteses within the first year.
11Results
- The mean volume of pleural fluid drained before
videothoracoscopy was 2,20,7 L (ranged from 1,3
to 3,4 L). - The average duration of the operations was 24 min
(ranged from 17 to 47 min). Endotracheal tubes
were removed in the operating room from all
patients. - The early postoperative period proceeded without
serious complications and deaths. - The average duration of drainage after operation
was 2,7 days (ranged from 1,5 to 7 days) - The average postoperative hospital stay was
7,00,5 days (ranged from 4 to 14 days).
12Results
- Temporary temperature rise occurred in 4 patients
(0,09) within first three days did not
exceed 38C. - No major chest pain symptom developed after the
operation. - The toxic effects connected with collagen
dispersion were not marked. - Dyspnea and cough were significantly reduced by
the procedure. - All patients were discharged from hospital in
good condition.
13Results
- Median survival after pleurodesis induction was
- 5,5 months for the patients with lung cancer and
- 9,1 months for the patients with breast cancer.
- To sum up, at the follow-up in 12 months there
were 5 patients with recurrences of effusion
(0,11). -
- In 40 of 45 patients (0,89) who underwent
thoracoscopic collagen insufflation
reaccumulation of pleural fluid was not
registered and additional thoracocentesis was not
required.
14Results
- In 1 month (45 patients alive)
- CR - 43 (0,96), PR - in 2 (0,04), F - 0
- In 3 months (41 patients alive)
- CR - 29 (0,71), PR - in 10 (0,24), F - 2
(0,05) - In 6 months (27 patients alive)
- CR - 16 (0,59), PR - in 7 (0,26), F - 4
(0,15) - In 12 months (11 patients alive)
- CR - 10 (0,91), PR - in 1 (0,09), F - 0
15Conclusion
- Videothoracoscopic powder collagen insufflation
is simple, safe and effective method of
biological pleurodesis induction in malignant
pleural effusions, which allows achieving
response and preventing relapses of fluid
accumulation in a pleural cavity in the majority
of patients.